What leaders in the field are looking forward to:
"Great opportunity for the RNAi community to come together to share thoughts, explore ideas and open up opportunities for collaboration"
Ali Shah, Co-Founder & CEO
Tallas Biotech
Brad Niles, CEO,
Ariz Precision Medicine
"This is the one meeting where I can come see and hear all the latest development in the RNAi field all in one place"
"This meeting provides a valuable ability to interact with others in the field and find out what each are doing to address difficult questions of relevance to us – namely how to achieve extrahepatic targeting and specifically targeted delivery to tumors"
David Evans, CSO,
Sirnaomics Inc
Guangnong (Sunny) Zhang, Associate Director,
Dicerna TRU of Novo Nordisk
"RNAi-Based Therapeutics Summit provides a great platform for us to share and exchange our learnings and expertise. Together, we are driving RNAi innovation"
"Great opportunity to connect with key scientists from both industry and academia. Improve understanding of the current RNAi therapy challenges and progress in the field"
Yao Xin, Principal Investigator,
Aro Biotherapeutics
Debasis Patra, VP CMC,
OliX US
"I think the Summit is an effective venue to exchange ideas and get update on the trend in oligonucleotides in the field of discovery, development, and manufacturing"